Civic AI
Procurement intelligence
Federal contract award
LUNGPACER MEDICAL USA INC LUNG-PROTECTIVE EFFECTS OF TRANSVENOUS DIAPHRAGM ACTIVATION IN PATIENTS WITH ARDS AOI #12: MITIGATING LONG-TERM EFFECTS (MILE) OF RESPIRATORY DISTRESS
LUNGPACER MEDICAL USA INC · Department of Health and Human Services
- Value
- $749,796
- Start
- May 1, 2023
- End
- Dec 15, 2027
- Action date
- Mar 18, 2026
- PIID
- 75A50123C00021
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- EXTON, PA
- Award type
- DEFINITIVE CONTRACT
Description
LUNGPACER MEDICAL USA INC LUNG-PROTECTIVE EFFECTS OF TRANSVENOUS DIAPHRAGM ACTIVATION IN PATIENTS WITH ARDS AOI #12: MITIGATING LONG-TERM EFFECTS (MILE) OF RESPIRATORY DISTRESS
Need modifications, related awards, and vendor peers? Open the full award workspace.